Lin H - Search Results

1

The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells.

Rothe K, Lin H, Lin KB, Leung A, Wang HM, Malekesmaeili M, Brinkman RR, Forrest DL, Gorski SM, Jiang X. Rothe K, et al. Among authors: lin kb, lin h. Blood. 2014 Jun 5;123(23):3622-34. doi: 10.1182/blood-2013-07-516807. Epub 2014 Apr 22. Blood. 2014. PMID: 24755409 Free article.

2

Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells.

Lin H, Chen M, Rothe K, Lorenzi MV, Woolfson A, Jiang X. Lin H, et al. Oncotarget. 2014 Sep 30;5(18):8637-50. doi: 10.18632/oncotarget.2353. Oncotarget. 2014. PMID: 25226617 Free PMC article.

3

New Mouse Models to Investigate the Efficacy of Drug Combinations in Human Chronic Myeloid Leukemia.

Lin H, Woolfson A, Jiang X. Lin H, et al. Methods Mol Biol. 2016;1465:187-205. doi: 10.1007/978-1-4939-4011-0_16. Methods Mol Biol. 2016. PMID: 27581149

4

The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML.

Lin H, Rothe K, Chen M, Wu A, Babaian A, Yen R, Zeng J, Ruschmann J, Petriv OI, O'Neill K, Maetzig T, Knapp DJHF, Nakamichi N, Brinkman R, Birol I, Forrest DL, Hansen C, Humphries RK, Eaves CJ, Jiang X. Lin H, et al. Blood. 2020 Jul 30;136(5):596-609. doi: 10.1182/blood.2019003636. Blood. 2020. PMID: 32270193 Free PMC article.

5

Feeder-free and serum-free in vitro assay for measuring the effect of drugs on acute and chronic myeloid leukemia stem/progenitor cells.

Lin H, Damen JE, Walasek MA, Szilvassy SJ, Turhan AG, Louis SA, Eaves AC, Wognum AW. Lin H, et al. Exp Hematol. 2020 Oct;90:52-64.e11. doi: 10.1016/j.exphem.2020.08.004. Epub 2020 Aug 13. Exp Hematol. 2020. PMID: 32798646 Free article.

6

Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.

Yen R, Grasedieck S, Wu A, Lin H, Su J, Rothe K, Nakamoto H, Forrest DL, Eaves CJ, Jiang X. Yen R, et al. Among authors: lin h. Leukemia. 2022 Oct;36(10):2443-2452. doi: 10.1038/s41375-022-01680-4. Epub 2022 Aug 23. Leukemia. 2022. PMID: 35999259 Clinical Trial.

7

Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.

Wu A, Yen R, Grasedieck S, Lin H, Nakamoto H, Forrest DL, Eaves CJ, Jiang X. Wu A, et al. Among authors: lin h. Leukemia. 2023 Dec;37(12):2426-2435. doi: 10.1038/s41375-023-02062-0. Epub 2023 Oct 17. Leukemia. 2023. PMID: 37848633

8

The anti-leukaemic effects and the mechanism of sodium selenite.

Jiang XR, Macey MG, Lin HX, Newland AC. Jiang XR, et al. Among authors: lin hx. Leuk Res. 1992;16(4):347-52. doi: 10.1016/0145-2126(92)90136-u. Leuk Res. 1992. PMID: 1314317

9

Engineered Lubricative Lecithin-Based Electrospun Nanofibers for the Prevention of Postoperative Abdominal Adhesion.

Li J, Lin H, Li J, Wang Y. Li J, et al. Among authors: lin h. Pharmaceutics. 2024 Dec 6;16(12):1562. doi: 10.3390/pharmaceutics16121562. Pharmaceutics. 2024. PMID: 39771542

10

Mining of Candidate Genes and Developing Molecular Markers Associated with Pokkah Boeng Resistance in Sugarcane (Saccharum spp.).

Lin H, Jiang Z, He T, Li G, Zhao M, Su L, Zhao J, Zou C, Yang X. Lin H, et al. Plants (Basel). 2024 Dec 14;13(24):3497. doi: 10.3390/plants13243497. Plants (Basel). 2024. PMID: 39771194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,863 results

Search Page

Filters